Holen Sie sich die Stockscreener-App
3.47
7.10%
0.23
Handel nachbörslich:
3.50
0.03
+0.86%
Schlusskurs vom Vortag:
$3.24
Offen:
$3.22
24-Stunden-Volumen:
3.49M
Relative Volume:
0.95
Marktkapitalisierung:
$423.35M
Einnahmen:
$58.36M
Nettoeinkommen (Verlust:
$-25.72M
KGV:
-9.5303
EPS:
-0.3641
Netto-Cashflow:
$-24.91M
1W Leistung:
-0.29%
1M Leistung:
-42.07%
6M Leistung:
-16.39%
1J Leistung:
+16.05%
1-Tages-Spanne:
$3.22
$3.50
1-Wochen-Bereich:
$3.155
$3.50
52-Wochen-Spanne:
$2.12
$7.55
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Firmenname
Aquestive Therapeutics Inc
Sektor
Telefon
908-941-1900
Adresse
30 TECHNOLOGY DRIVE, WARREN, NJ
Vergleichen Sie AQST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
3.47 | 395.29M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
124.96 | 54.61B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.91 | 52.47B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.42 | 46.18B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.53 | 36.87B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
476.78 | 20.38B | 3.08B | 1.24B | 1.07B | 25.61 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2024-12-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-05-10 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-11 | Eingeleitet | Piper Sandler | Overweight |
| 2024-03-28 | Eingeleitet | Raymond James | Outperform |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-04-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-01-03 | Eingeleitet | Lake Street | Buy |
| 2018-08-20 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-08-20 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Aquestive Therapeutics Inc Aktie (AQST) Neueste Nachrichten
Fed Watch: Can Aquestive Therapeutics Inc grow without external funding2025 Momentum Check & AI Forecasted Entry/Exit Points - baoquankhu1.vn
SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - TMX Newsfile
INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - The Malaysian Reserve
Jim Cramer on Aquestive Therapeutics: “I’m not sure if they deserve the benefit of the doubt” - MSN
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc.AQST - yourwyominglink.com
What’s the RSI of Aquestive Therapeutics Inc. stockJuly 2025 Opening Moves & AI Forecast for Swing Trade Picks - mfd.ru
AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - FinancialContent
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc.AQST - marketscreener.com
Jim Cramer on Aquestive Therapeutics: “I’m Not Sure If They Deserve the Benefit of the Doubt” - Insider Monkey
Jim Cramer on Crinetics: “That’s a Better Spec Than Aquestive” - Yahoo Finance
Jim Cramer Recently Looked at These 25 Stocks - Insider Monkey
AQUESTIVE ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
How does Aquestive Therapeutics Inc. score in quality rankingsWeekly Loss Report & Technical Confirmation Alerts - bollywoodhelpline.com
Faruqi & Faruqi Investigates Aquestive Therapeutics After 40% Stock Plunge Due to FDA Concerns - Intellectia AI
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - PR Newswire
Shorts Report: Is Aquestive Therapeutics Inc backed by strong institutional buyingQuarterly Investment Review & Verified Technical Trade Signals - baoquankhu1.vn
Kaplan Fox & Kilsheimer LLP is Investigating Aquestive Therapeutics, Inc. (AQST) for Potential Securities Law Violations - NewMediaWire
About Us - FinancialContent
Peering Into Aquestive Therapeutics Inc's Recent Short Interest - Benzinga
A Look At Aquestive Therapeutics (AQST) Valuation After Anaphylm Regulatory Update And FDA Feedback - Sahm
Commonwealth Equity Services LLC Takes $5.92 Million Position in Aquestive Therapeutics, Inc. $AQST - MarketBeat
Here's Why Aquestive Therapeutics (AQST) Is a Great 'Buy the Bottom' Stock Now - sharewise.com
Rate Hike: Is Aquestive Therapeutics Inc gaining market share2025 Price Momentum & Low Drawdown Trading Strategies - baoquankhu1.vn
Levi & Korsinsky Investigates Possible Securities Fraud by Aquestive Therapeutics, Inc. (AQST) - marketscreener.com
Trend Review: How does Aquestive Therapeutics Inc score in quality rankingsJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Aquestive Therapeutics Inc. (AQST) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aquestive Therapeutics Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through the Firm's Investigation - TradingView
Aquestive drops as FDA flags issues in Anaphylm marketing application - MSN
Aquestive Therapeutics: Anaphylm Will Probably Survive This Regulatory Hurdle - Seeking Alpha
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - marketscreener.com
Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround - Yahoo Finance
Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies in Anaphylm FilingWhat's Changed - Sahm
Assessing Aquestive Therapeutics (AQST) Valuation After FDA Flags Anaphylm Application Deficiencies - Yahoo Finance
Oklo, Applied Digital, Opendoor Technologies, Vistra, Aquestive Therapeutics: Stocks making the biggest moves today - MSN
Why Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies In Anaphylm Application – And What's Next - Yahoo Finance
Benzinga Bulls And Bears: Chevron, Palantir, Aquestive — And Real Estate Stocks Plummet - Benzinga
Lake Street Reaffirms Their Buy Rating on Aquestive Therapeutics (AQST) - The Globe and Mail
AQST Stock Plunges On An FDA Setback For Its Allergy Drug – Here’s What Has Changed - Stocktwits
Sector Update: Health Care - MarketScreener
Aquestive Therapeutics Stock Dips Amid Financial Challenges - StocksToTrade
Oklo, Applied Digital, Opendoor Technologies, Vistra, Aquestive Therapeutics: Stocks Making The Biggest Moves Today - Stocktwits
INVESTOR ALERT: Investigation of Aquestive Therapeutics, Inc. (AQST) by Holzer & Holzer, LLC - GlobeNewswire
Is Aquestive Therapeutics Inc. stock oversold or undervalued2025 Price Targets & Accurate Entry and Exit Point Alerts - ulpravda.ru
Finanzdaten der Aquestive Therapeutics Inc-Aktie (AQST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
9.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):